CELL-FREE
DNA - BIOTECHNOLOGY 
News:
Cell-free DNA promises to
transform how we find diseases
What's
in the news?
●    
Cell-free
DNA (cfDNA) is a useful technique that is being used by researchers all over
the world to better understand human
diseases and enhance diagnosis, monitoring, and prognosis.
What is Cell-free DNA?
●    
Small nucleic acid fragments known as
CfDNA are discovered in bodily fluids outside of cells after being discharged
from cells.
●    
It
was initially noticed in the blood of pregnant women in the late 1940s, which
is when it was first discovered.
●    
Cell
death and other physiological processes, for example, can both manufacture and
release cfDNA from the cells.
●    
Several
disease processes, including autoimmune conditions like systemic lupus
erythematosus, are linked to the release of cfDNA.
How is Cell Free DNA different from
Normal DNA?
| 
   Cell
  Free DNA  | 
  
   Normal
  DNA  | 
 
| 
   It is found
  in the bloodstream and other fluids present in the body.  | 
  
   Found within the cell nucleus or mitochondria.  | 
 
| 
   It is used in
  Forensic for DNA profiling and investigations.  | 
  
   It is not used in Forensic.  | 
 
| 
   It exists in
  Fragmented form.  | 
  
   It exists in the form of a double helix structure.  | 
 
| 
   It can be used in detecting infectious diseases.  | 
  
   It is not used for detecting infectious diseases.  | 
 
Applications
of cfDNA:
1.
Non-Invasive Prenatal Testing:  
●       One
of the most widely used applications of cfDNA has been in screening foetuses
for specific chromosomal abnormalities.
●       The
availability of affordable genome-sequencing approaches will allow clinicians
to sequence cfDNA fragments that correspond to foetal DNA. 
●       They
can then use it to understand specific
chromosomal abnormalities that involve changes in the chromosomal copy
number. 
●       Such
changes can lead to conditions like Down’s
syndrome, which is due to a change in chromosome 21.
2.
Monitoring Cancer:
●       Researchers
have developed a new test they have dubbed ‘Genome-wide
Mutational Incidence for Non-Invasive detection of cancer’, or ‘GEMINI’. 
●       This
is a type of genetic mutation that, when combined with machine-learning
approaches, could provide a way to detect cancer early. 
●       Using
a particular machine-learning model, some genomic data, and data from a
computed tomography (CT) scan, the researchers could successfully detect lung
cancer.
●       It
was discovered to be able to identify over 300 people who had a very high risk
of acquiring lung cancer.
3.
Organ Transplantation: 
●       Using
cfDNA applications, it may be possible to determine why the body is rejecting a
transplanted organ. Here, donor-derived
cfDNA, also known as dd-cfDNA, can be used to obtain an early yet precise
estimation of how well the organ is being assimilated.
4.
Other Uses: 
●       CfDNA
could be employed as a biomarker for
metabolic diseases like type 2 diabetes and non-alcoholic fatty liver
disease, as well as neurological disorders like Alzheimer's disease, neuronal
tumors, stroke, and traumatic brain damage.